Altered Pharmacokinetics of Vinblastine in Mdr1a P-glycoprotein-Deficient Mice
Judith van Asperen(University of Groningen), Olaf van Tellingen(Dutch Cancer Society), Alfred H. Schinkel(Oncode Institute), Piet Borst(The Netherlands Cancer Institute), Jos H. Beijnen(The Netherlands Cancer Institute), W J Nooijen
Cited by 177
Related Papers
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
|Proceedings of the National Academy of Sciences|1997|941
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884